ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 727,46
1,28%
DAX
18 518,03
-0,44%
Brent Oil
83,405
-1,11%
Bitcoin
64 949,87
0,17%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hvivo Plc (HVO)

  7. Hvivo Plc (HVO) Actualités

HVO

Hvivo (HVO)

Hvivo Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:HVO
DateHeureSourceTitreSymboleSociété
11/01/202108h00UK RegulatoryOpen Orphan PLC First volunteer dosed in COVID-19 clinical trialLSE:HVOHvivo Plc
06/01/202117h29UK RegulatoryOpen Orphan PLC Holding(s) in CompanyLSE:HVOHvivo Plc
06/01/202115h37Alliance NewsAlliance NewsIN BRIEF: Open Orphan Inks Contract Renewal With Top-3 Pharma ClientLSE:HVOHvivo Plc
06/01/202108h00UK RegulatoryOpen Orphan PLC Contract renewal with top-3 pharmaceutical clientLSE:HVOHvivo Plc
31/12/202008h00UK RegulatoryOpen Orphan PLC Rule 19.6(c) ConfirmationLSE:HVOHvivo Plc
23/12/202020h50Alliance NewsAlliance NewsUK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA BoostLSE:HVOHvivo Plc
23/12/202008h00RNS Non-RegulatoryOpen Orphan PLC Successful completion of toxicology studyLSE:HVOHvivo Plc
22/12/202015h26Alliance NewsAlliance NewsIN BRIEF: Open Orphan Pens Contract Extension With Major ClientLSE:HVOHvivo Plc
14/12/202023h04Alliance NewsAlliance NewsUK TRADING UPDATE SUMMARY: Novacyt Unveils New Test For Mink CovidLSE:HVOHvivo Plc
14/12/202008h30UK RegulatoryOpen Orphan PLC Exercise of Share OptionsLSE:HVOHvivo Plc
14/12/202008h00UK RegulatoryOpen Orphan PLC MHRA approval for nasal COVID-19 vaccine trialLSE:HVOHvivo Plc
07/12/202008h00UK RegulatoryOpen Orphan PLC Venn Life Sciences contract winsLSE:HVOHvivo Plc
24/11/202017h27Alliance NewsAlliance NewsUK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head ExitsLSE:HVOHvivo Plc
24/11/202008h00UK RegulatoryOpen Orphan PLC Directors ChangeLSE:HVOHvivo Plc
19/11/202022h18Alliance NewsAlliance NewsIN BRIEF: Open Orphan To Lead Challenge Agent Development ConsortiumLSE:HVOHvivo Plc
19/11/202008h00RNS Non-RegulatoryOpen Orphan PLC Collaboration with HIC-VAC and Wellcome TrustLSE:HVOHvivo Plc
05/11/202017h32Alliance NewsAlliance NewsIN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza StudyLSE:HVOHvivo Plc
05/11/202008h00UK RegulatoryOpen Orphan PLC New GBP2.5m Influenza Challenge Study Contract WinLSE:HVOHvivo Plc
30/10/202012h07Alliance NewsAlliance NewsOpen Orphan Inks Two-Year Contract With Tier 1 German Pharma CompanyLSE:HVOHvivo Plc
30/10/202012h00UK RegulatoryOpen Orphan PLC Price Monitoring ExtensionLSE:HVOHvivo Plc
30/10/202008h51Alliance NewsAlliance News*Open Orphan Inks 2-Year Contract With Unnamed Tier 1 German Pharma CompanyLSE:HVOHvivo Plc
30/10/202008h00UK RegulatoryOpen Orphan PLC New 2-year contract with a tier 1 German companyLSE:HVOHvivo Plc
20/10/202016h59Alliance NewsAlliance NewsIN BRIEF: Open Orphan To Develop Covid Study Model For UK GovernmentLSE:HVOHvivo Plc
20/10/202008h00UK RegulatoryOpen Orphan PLC Contract Signed with UK GovernmentLSE:HVOHvivo Plc
16/10/202016h24Alliance NewsAlliance NewsIN BRIEF: Open Orphan In Talks With UK Government Over Corona StudyLSE:HVOHvivo Plc
16/10/202009h47UK RegulatoryOpen Orphan PLC Statement re further media commentLSE:HVOHvivo Plc
30/09/202019h37Alliance NewsAlliance NewsUK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue RiseLSE:HVOHvivo Plc
30/09/202008h00UK RegulatoryOpen Orphan PLC Interim Results for 6 months ended 30 June 2020LSE:HVOHvivo Plc
28/09/202020h34Alliance NewsAlliance NewsIN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study ContractLSE:HVOHvivo Plc
28/09/202008h00UK RegulatoryOpen Orphan PLC New GBP4.3m Challenge Study Contract WinLSE:HVOHvivo Plc
 Showing the most relevant articles for your search:LSE:HVO

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
DG
Vinci
EU
PX1
CAC 40
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
NASDAQ
MSFT
Microsoft
EU
RI
Pernod Ricard
EU
VIV
Vivendi
EU
BN
Danone
NASDAQ
NVDA
NVIDIA
EU
RNO
Renault
EU
ACA
Credit Agricole
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés